Insurance Denied Radiation Therapy — Appeal Guide for Cancer Patients

Radiation therapy is a cornerstone of cancer treatment — used to cure early-stage cancers, shrink tumors before surgery, eliminate residual disease after surgery, and relieve symptoms in advanced disease. When your insurer denies it, the denial may feel absurd. But it happens, and for specific radiation techniques the fight can be particularly difficult. Here is how to navigate it.

Types of Radiation Denials

Radiation therapy denials tend to fall into a few categories:

• Standard radiation denied as "not medically necessary": Even conventional external beam radiation is sometimes denied when the insurer's reviewer questions the treatment plan's appropriateness.
• Intensity-Modulated Radiation Therapy (IMRT) denied: Insurers may cover standard radiation but deny IMRT, claiming the standard technique is adequate — even when IMRT's greater precision reduces critical toxicity (e.g., for prostate, head and neck, gynecologic cancers).
• Stereotactic Body Radiation Therapy (SBRT/SABR) denied: Highly targeted treatment for early-stage lung cancer, liver tumors, and spinal metastases is sometimes classified as experimental despite strong evidence.
• Proton therapy denied: Proton beam therapy is frequently denied as experimental or not medically necessary, particularly for pediatric cancers, skull base tumors, and CNS malignancies — despite significant evidence of reduced toxicity.
• Number of fractions denied: Insurer disputes the number of treatment sessions prescribed, arguing a shorter course is adequate.
• Treatment for recurrent disease: Insurers sometimes deny reirradiation or radiation for recurrent or metastatic disease.

Clinical Guidelines Supporting Radiation

The National Comprehensive Cancer Network (NCCN), American Society for Radiation Oncology (ASTRO), and American Society of Clinical Oncology (ASCO) provide the clinical foundation for radiation appeals:

• NCCN guidelines list radiation therapy as a recommended component of treatment for many cancer types at specific stages. If your radiation is guideline-concordant, cite the specific NCCN category recommendation.
• ASTRO has published model policies for IMRT, SBRT, and proton therapy that define the clinical indications where these techniques are appropriate. These model policies are directly cited in many insurance coverage policies — and should be cited in your appeal.
• For proton therapy, ASTRO model policies identify clear indications where proton therapy is favored: pediatric malignancies (to minimize growth and developmental effects of radiation), skull base tumors, chordomas, ocular melanoma, and CNS tumors near critical structures.

IMRT vs. Conventional Radiation

If your IMRT is being denied in favor of conventional radiation, your radiation oncologist must document why IMRT is the appropriate technique. The standard argument:

• IMRT delivers higher conformality, reducing dose to critical normal structures (spinal cord, bladder, rectum, salivary glands depending on site).
• For prostate cancer, head and neck cancer, gynecologic cancer, and anal canal cancer, IMRT has become the standard of care because of its superior toxicity profile — not as an expensive luxury.
• Cite ASTRO model policy for IMRT and the specific clinical indication matching your cancer type.

Proton Therapy: A Harder Battle, But Winnable

Proton therapy denials require the most detailed appeals. Your radiation oncologist needs to document:

1. Why proton therapy is preferred for your specific tumor location (proximity to critical structures).
2. Why conventional photon radiation would deliver unacceptable dose to those structures.
3. Dosimetric comparison (if available) showing proton therapy's dosimetric superiority in your specific case.
4. ASTRO model policy or published literature supporting proton therapy for your specific indication.

Many proton therapy centers have dedicated appeals teams and can help you navigate this process.

Building Your Radiation Appeal

Include:

1. Radiation oncologist's letter of medical necessity — cancer type, stage, proposed treatment technique, fractionation, and clinical rationale.
2. NCCN guideline reference supporting radiation as a recommended treatment.
3. ASTRO model policy or guideline supporting the specific technique (IMRT, SBRT, proton).
4. Dosimetric data if the debate is about IMRT vs. conventional or proton vs. photon.
5. Multidisciplinary tumor board recommendation if one was made — this carries significant weight.
6. Urgency documentation if treatment delay will allow disease progression.

Expedited Appeals for Radiation

Radiation therapy is often time-sensitive, particularly for tumors where delay allows progression. Always request expedited review with documentation from your radiation oncologist of why delay is medically harmful.

Advocacy Resources

• American Cancer Society (cancer.org) — 1-800-227-2345
• ASTRO Patient Information (rtanswers.org) — radiation therapy patient education
• Cancer Care (cancercare.org) — financial and emotional support
• Patient Advocate Foundation (patientadvocate.org)

Fight Back With ClaimBack

Radiation therapy is a precision, evidence-based treatment that saves lives — and insurers who deny it without clinical justification need to hear from you. ClaimBack helps cancer patients and their treatment teams build targeted, guideline-backed radiation therapy appeals.

Start your appeal at https://claimback.app/appeal.

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Common Reasons Insurance Claims Are Denied